DFX Intelligence

Venture Capital Intelligence

Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

People / Charles W Johnson

Charles W Johnson

Managing partnerManaging PartnerFCA Health Innovations II Management LLCTN

Roles

3 current, 0 past

FCA Management Group, LLC Member
Apr 1, 2026 to present · “Schedule A: Johnson, Charles, W, MEMBER, since 04/2026, ownership C, control person Y”
Fact IAPD Form ADV Part 1 PDF per firm (current filing, Schedule D 7.B.(1) and Schedule A)
FCA Health Innovations II Management LLC Managing Partner
Oct 1, 2020 to present · “Schedule A: Johnson, Charles, W, MANAGING PARTNER, since 10/2020, ownership B, control person Y”
Fact SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Dioko Management LLC Managing Partner
Jan 1, 2016 to present · “Schedule A: Johnson, Charles, W, MANAGING PARTNER, since 01/2016, ownership B, control person Y”
Fact SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)

Investments attributed to this person

No investment attributed yet. Attribution needs a source naming this person on the deal: a quote, a board seat, a portfolio page credit.

Board seats and vehicles

0 boards, 2 vehicles

FCA Health Innovations III AI, LP Executive Officer May 15, 2026
FCA Health Innovations III QP, LP Executive Officer May 15, 2026

Timeline

No dated event.